Among the ten genes included in the NGS panel (BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, PMS2, RAD51C, RAD51D, and TP53), a total of 3457 variants was annotated and classified among the remaining 95 tumor samples. This evidence concerns the gene PMS2 and neoplasm.